Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06325293 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study

Study acronym: MYTHIC
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Site details revised at 13 of 13 sitesv6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2025 to Jan 28, 2025
    • Site details revised at 13 of 13 sites
    • Collaborators expanded, about 9 words
    v5
  4. Start date: Jul 1, 2024 to Jan 1, 2025
    • Primary completion date: Jun 30, 2028 to Nov 30, 2028
    • Study completion date: Jun 30, 2028 to Dec 31, 2028
    v4
  5. 2 versions Re-verified since May 29, 2024, no change to tracked fieldsv2-v3
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare a placebo (a look-alike substance that contains no active drug) with a commonly used antibiotic in children with Mycoplasma pneumoniae (a specific bacterium) induced community-acquired pneumonia. The main question it aims to answer is: Is antibiotic treatment needed in Mycoplasma pneumoniae (a specific bacterium) induced pneumonia? Participants will receive either a placebo or a antibiotic treatment and track their symptoms and vital signs until they are healthy. Researchers will then compare the length of symptoms between the placebo and the antibiotic group.
Trial Details
NCT Number NCT06325293
Lead Sponsor Christoph Berger
Collaborators: Swiss National Science Foundation, Swiss Clinical Trial Organisation, SwissPedNet
Conditions
(from sponsor)		 Community Acquired Pneumonia in Children, Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia
Related terms Community-Acquired Pneumonia, Pneumonia, Mycoplasma
Enrollment 376 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov